Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial. Guo Y, Lane DA, Chen Y, Lip GYH, et al. Am J Med 2020;133:1195-1202.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo Y, Lane DA, Chen Y, Lip GYH, et al. Regular Bleeding Risk Assessment Associated with Reduction in Bleeding Outcomes: The mAFA-II Randomized Trial. Am J Med 2020;133:1195-1202.
PMID: 32289310